17 Jun 2021 16:28
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BN7ZCY67
Issuer Name
ERGOMED PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Aggregate of Standard Life Aberdeen plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios
City of registered office (if applicable)
Edinburgh
Country of registered office (if applicable)
United Kingdom
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
16-Jun-2021
6. Date on which Issuer notified
17-Jun-2021
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
Resulting situation on the date on which threshold was crossed or reached | 10.426520 | 0.000000 | 10.426520 | 5,087,170 |
Position of previous notification (if applicable) | 10.26 | 0.00 | 10.26 |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
GB00BN7ZCY67 | 5,087,170 | 10.426520 | ||
Sub Total 8.A | 5,087,170 | 10.426520 | ||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
Sub Total 8.B1 | ||||
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
Sub Total 8.B2 | |||||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
Standard Life Aberdeen plc | ||||
Standard Life Aberdeen plc | Standard Life Investments (Holdings) Limited | |||
Standard Life Aberdeen plc | Standard Life Investments Limited | 10.089525 | 10.089525 | |
Standard Life Aberdeen plc | ||||
Standard Life Aberdeen plc | Aberdeen Asset Management PLC | |||
Standard Life Aberdeen plc | Aberdeen Asset Managers Limited | |||
Standard Life Aberdeen plc | ||||
Standard Life Aberdeen plc | Standard Life Investments (Holdings) Limited | |||
Standard Life Aberdeen plc | Aberdeen Standard Capital Limited |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
In reference to section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.This disclosure reflects the fact that the voting rights effectively held indirectly by the underlying intermediate holding company Standard Life Investments (Holdings) Limited ("SLIHL") and held by the underlying investment management entity Standard Life Investments Limited ("SLIL") increased above the 10% notifiable thresholds due to trading on 16 June 2021. SLIHL now effectively holds 10.108229% and SLIL now holds 10.089525% of the delegated voting rights of the shares in Ergomed plc.
12. Date of Completion
17-June-2021
13. Place Of Completion
Edinburgh, United Kingdom